Literature DB >> 28118623

Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Multicenter International Study of GELF.

Pierre Gay1, Benoit Wallaert, Stefan Nowak, Jonas Yserbyt, Stavros Anevlavis, Christophe Hermant, Alban Lovis, Olivier Menard, Bernard Maitre, Thomas Vandemoortele, Hervé Dutau, Amandine Briault, Arnaud Bourdin, Jean-Michel Vergnon, Marios E Froudarakis.   

Abstract

BACKGROUND: New therapies have emerged in the treatment of pulmonary alveolar proteinosis (PAP) and, therefore, there is a real need to evaluate the efficacy of whole-lung lavage (WLL) in this rare disease.
OBJECTIVES: The aim of this study was to assess the efficacy of WLL in patients with PAP.
METHODS: We included 33 patients from 12 centers, which are members of the French-Speaking Thoracic Endoscopy Group, for analysis. Data collection concerned patients and disease characteristics, pulmonary function tests (PFTs) and technical information on the procedure.
RESULTS: The median age of the patients was 44 years (range 13-77). There were 23 (71.9%) patients with respiratory insufficiency at presentation. All patients underwent WLL by general anesthesia and selective lung ventilation, except 1 who underwent awake flexible bronchoscopy. We noted differences in the technique, as 12 (36.36%) patients had percussion during the procedure and only 4 (12.1%) patients underwent 2-lung lavage during 1 anesthesia. A median of 12 L was used to perform WLL (1.0-40 L). Complications occurred in 11 (33.3%) patients, and 18 (56.25%) of them relapsed in a median period of 16.9 months. No significant changes were found in any PFT parameters studied, except for PaO2, which was significantly improved by 6.375 mm Hg (p = 0.0213) after the procedure compared to before.
CONCLUSIONS: Although the application of the WLL technique was variable, overall, it significantly improved patients' short-term respiratory condition by improving PaO2. However, a long-term effect needs to be confirmed, as many of our patients relapsed.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2017        PMID: 28118623     DOI: 10.1159/000455179

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  11 in total

1.  Novel method of noninvasive ventilation supported therapeutic lavage in pulmonary alveolar proteinosis proves to relieve dyspnea, normalize pulmonary function test results and recover exercise capacity: a short communication.

Authors:  Szymon Skoczynski; Katarzyna Wyskida; Patrycja Rzepka-Wrona; Magdalena Wyskida; Ewa Uszok-Gawel; Dawid Bartocha; Lukasz Krzych; Wladysław Pierzchala; Adam Barczyk
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 2.  Whole lung lavage-technical details, challenges and management of complications.

Authors:  Ahmed Awab; Muhammad S Khan; Houssein A Youness
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

3.  How We Do It: Whole Lung Lavage.

Authors:  Deepa Shrestha; Sahajal Dhooria; Ganesh Kumar Munirathinam; Inderpaul Singh Sehgal; Kuruswamy Thurai Prasad; Babu Ram; Harkant Singh; Ashutosh N Aggarwal; Goverdhan D Puri; Valliappan Muthu; Ritesh Agarwal
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-06-29       Impact factor: 1.803

4.  Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up.

Authors:  Xinlun Tian; Yanli Yang; Lulu Chen; Xin Sui; Wenshuai Xu; Xue Li; Xiaobei Guo; Lingshan Liu; Yusen Situ; Jun Wang; Yang Zhao; Shuzhen Meng; Wei Song; Yonglong Xiao; Kai-Feng Xu
Journal:  Orphanet J Rare Dis       Date:  2020-07-02       Impact factor: 4.123

5.  Management of primary pulmonary alveolar proteinosis: A multicentric experience.

Authors:  Vikas Marwah; C D S Katoch; Sarvinder Singh; Ajay Handa; Vasu Vardhan; A K Rajput; M S Barthwal; D Bhattacharyya; S P Rai
Journal:  Lung India       Date:  2020 Jul-Aug

6.  Respiratory failure in a 28-year-old male.

Authors:  Danny Wadden; Alvan Buckley; Chandrani Ghosh; Gokul Vidyasankar
Journal:  Breathe (Sheff)       Date:  2020-06

7.  One-session bilateral sequential whole lung lavage (OSBSWLL) for the management of pulmonary alveolar proteinosis.

Authors:  Javier Diaz-Mendoza; Eduardo Celis Valdiviezo; Niral M Patel; Michael J Simoff
Journal:  BMC Pulm Med       Date:  2021-11-09       Impact factor: 3.317

8.  Increased Efficacy of Whole Lung Lavage Treatment in Alveolar Proteinosis Using a New Modified Lavage Technique.

Authors:  L Agnes Grutters; Elseline C Smith; Cees W Casteleijn; Eric P van Dongen; Henk J Ruven; Joanne J van der Vis; Marcel Veltkamp
Journal:  J Bronchology Interv Pulmonol       Date:  2021-07-01

9.  Efficacy of whole lung lavage in pulmonary alveolar proteinosis: a 20-year experience at a reference center in Thailand.

Authors:  Punchalee Kaenmuang; Asma Navasakulpong
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

10.  Alveolar proteinosis due to toxic inhalation at workplace.

Authors:  Gabriela F Santos; João Portela; Despoina Argyropoulou; Rita Varudo; Inês Pimenta; Ana Oliveira; Sara Lança; Antero Fernandes
Journal:  Respir Med Case Rep       Date:  2020-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.